| Hang Seng Index | 25.840 HKD | +0.220 | +0.859% | 418.39M | 10.77B | 25.623 (+0.847%) HKD as at 2025/08/21 | | |
| Hang Seng China Enterprises | 92.840 HKD | +1.040 | +1.133% | 112.38M | 10.38B | 91.830 (+1.100%) HKD as at 2025/08/21 | | |
| Hang Seng TECH Index | 5.540 HKD | +0.140 | +2.593% | 1.26B | 6.94B | 5.400 (+2.587%) HKD as at 2025/08/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.680 HKD | +0.275 | +5.088% | 213.99M | 1.20B | 5.417 (+4.853%) HKD as at 2025/08/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.492 HKD | -0.082 | -5.210% | 502.73M | 762.17M | 1.572 (-5.107%) HKD as at 2025/08/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.830 HKD | +0.100 | +1.745% | 54.82M | 316.89M | 5.731 (+1.727%) HKD as at 2025/08/21 | | |
| CSI 300 | 49.540 HKD | +1.060 | +2.186% | 5.13M | 252.30M | 48.264 (+2.644%) HKD as at 2025/08/21 | | |
| Hang Seng TECH Index | 11.870 HKD | +0.280 | +2.416% | 19.68M | 232.29M | 11.587 (+2.442%) HKD as at 2025/08/21 | | |
| FTSE China A50 | 15.720 HKD | +0.320 | +2.078% | 14.08M | 219.98M | 15.375 (+2.242%) HKD as at 2025/08/21 | | |
| Hang Seng TECH Index | 5.630 HKD | +0.145 | +2.644% | 34.23M | 191.08M | 5.484 (+2.660%) HKD as at 2025/08/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.966 HKD | -0.036 | -1.798% | 81.82M | 162.02M | 2.002 (-1.808%) HKD as at 2025/08/21 | | |
| Hang Seng China Enterprises | 10.770 HKD | +0.060 | +0.560% | 9.79M | 105.18M | 10.673 (+0.913%) HKD as at 2025/08/21 | | |
| FTSE China A50 | 14.640 HKD | +0.310 | +2.163% | 5.50M | 79.72M | 14.321 (+2.225%) HKD as at 2025/08/21 | | |
| SSE Science and Technology Innovation Board 50 Index | 11.610 HKD | +1.020 | +9.632% | 6.44M | 73.77M | 10.576 (+9.777%) HKD as at 2025/08/21 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.520 HKD | +0.230 | +1.330% | 2.73M | 47.51M | 17.313 (+1.197%) HKD as at 2025/08/21 | | |
| CSI 300 | 32.400 HKD | +0.700 | +2.208% | 1.16M | 37.26M | 31.597 (+2.542%) HKD as at 2025/08/21 | | |
| MSCI China A 50 Connect Index (net total return index) | 26.340 HKD | +0.700 | +2.730% | 1.23M | 32.52M | 25.596 (+2.905%) HKD as at 2025/08/21 | | |
| London Gold Fixing Price | 2,401.000 HKD | -2.000 | -0.083% | 13.38K | 32.06M | N/A | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.508 HKD | +0.192 | +4.449% | 5.73M | 25.44M | 4.298 (+4.891%) HKD as at 2025/08/21 | | |
| MSCI India Net Total Return (USD) Index | 6.950 HKD | -0.160 | -2.250% | 3.41M | 23.74M | 7.028 (-1.107%) HKD as at 2025/08/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.884 HKD | +0.052 | +1.357% | 5.94M | 23.08M | 3.872 (+0.313%) HKD as at 2025/08/21 | | |
| Hang Seng High Dividend Yield | 30.500 HKD | 0.000 | 0.000% | 725.51K | 22.03M | 30.443 (+0.187%) HKD as at 2025/08/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 5.800 HKD | +0.410 | +7.607% | 2.88M | 16.37M | 5.387 (+7.675%) HKD as at 2025/08/21 | | |
| FactSet China Semiconductor Index (net total return) | 50.820 HKD | +3.800 | +8.082% | 292.75K | 14.50M | 46.990 (+8.150%) HKD as at 2025/08/21 | | |
| CSI 300 | 45.600 CNY | +1.160 | +2.610% | 242.48K | 10.92M | 44.360 (+2.795%) CNY as at 2025/08/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.594 HKD | +0.009 | +1.538% | 18.19M | 10.80M | 0.592 (+0.355%) HKD as at 2025/08/21 | | |
| SSE Science and Technology Innovation Board 50 Index | 8.405 HKD | +0.680 | +8.803% | 1.30M | 10.61M | 7.681 (+9.423%) HKD as at 2025/08/21 | | |
| Short-term deposits and high quality money market investments | 9,364.000 HKD | +8.450 | +0.090% | 1.12K | 10.46M | 9,350.353 (+0.146%) HKD as at 2025/08/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 16.560 HKD | -0.100 | -0.600% | 613.00K | 10.17M | 16.659 (-0.591%) HKD as at 2025/08/21 | | |
| CME Bitcoin Futures | 38.020 HKD | -0.200 | -0.523% | 261.00K | 9.91M | 37.673 (+0.921%) HKD as at 2025/08/21 | | |